Results 161 to 170 of about 25,840,332 (309)
Using system dynamics to understand barriers to cost reduction
Thesis (S.M.)--Massachusetts Institute of Technology, System Design & Management Program, 2000.Includes bibliographical references (v. 2, leaves 340-342).by William L.
Blake, William L. (William Lawrence), 1970-
core
Document Preparation for Electronic Document Management System [PDF]
Mohamad Azri Mohamad Radzi +3 more
openaire +1 more source
microRNA‐7‐5p and α‐Synuclein SAA Predict Parkinson's Disease Phenoconversion
ABSTRACT Objective Corroborate blood neuron‐derived extracellular vesicle (NDEV) alpha‐synuclein (αSyn), the CSF αSyn seed amplification assay (αSyn‐SAA), and blood microRNA‐7‐5p (miR‐7‐5p) as markers for Parkinson's disease (PD) phenoconversion and determine if combining these markers would help select subjects who would be more likely to phenoconvert.
Shayan Zadegan +4 more
wiley +1 more source
Direct cost of trabeculectomy in the Brazilian public health system: a micro-costing analysis in a university hospital. [PDF]
Cabral JA +9 more
europepmc +1 more source
Thesis (S.M.)--Massachusetts Institute of Technology, System Design & Management Program, 2001.Includes bibliographical references (leaves 104-105).by Sean M.
Newell, Sean M. (Sean Michael), 1970-
core
System Development for Document Management System [PDF]
Fatin Hazwani Kiplie +3 more
openaire +1 more source
Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley +1 more source
[Expansion of access to specialized care: the experience of Regional Health Consortia in Bahia, Brazil]. [PDF]
Souza LEPF +7 more
europepmc +1 more source
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos +2 more
wiley +1 more source
Health system strategies for adaptation to drought: A global scoping review. [PDF]
Khosravifar A +8 more
europepmc +1 more source

